Leaderboard

En | De
No articles selected!     View Cart  
You are here: Psychiatry » Schizophrenia and Psychotic Disorders 02. July 2026
Search
medline.ch
Schizophrenia and Psychotic Disorders
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Anxiety Disorders
Dementia
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3462  Previews Next
   
   Articles 1 - 20 / 69221  
   
Shared genetic architecture of schizophrenia and Alzheimer's disease and related dementias implicates 16p11.2 and lifespan brain vulnerability.
Mol Psychiatry
Chen Y, Cheng L, Wang Q, Liu Q, Li W, Wang C, Lv L, Yue W.
PMID: 42387103 [PubMed - as supplied by publisher]


Developmental Trauma as a Prognostic Factor for Later Psychotic Disorder in an Adolescent Clinical Cohort: A 20-Year Follow Up Study.
Acta Psychiatr Scand
Kieseppä V, Díaz-Caneja CM, Rutten BPF, Riipinen P, Gülöksüz S, Kelleher I.
PMID: 42386520 [PubMed - as supplied by publisher]


Severe Mental Illness Longitudinal Evaluation (SMILE): protocol for establishing a cohort and bioresource for UK-based patients with psychosis.
BMJ Open
Quinn A, Johnson T, Bieles J, Booth L, McCutcheon RA, Bradley J, Kingston N, Breen G, Harshfield A, Murray GK, Walters JTR, Perry BI, Ul Haq Katshu MZ, Kendall K, Upthegrove R.
PMID: 42386305 [PubMed - indexed for MEDLINE]


Semaglutide in Schizophrenia-A Top Clinical Trial.
JAMA Psychiatry
Öngür D.
PMID: 42384388 [PubMed - as supplied by publisher]


Clinical High-Risk for Psychosis in Latinx Populations: Common Issues and Recommendations for Improving Care.
Early Interv Psychiatry
Delgado D, James SH, Strauss GP, Galvan T.
PMID: 42383579 [PubMed - indexed for MEDLINE]


Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for Psychosis.
Early Interv Psychiatry
Hakamuwa Lekamlage D, Ang LMA, Sominsky L, Wood SJ, McGorry PD, Mei C, Amminger GP, Yuen HP, Kerr M, Spark J, Wallis N, Polari A, Baird S, Buccilli K, Dempsey SA, Ferguson N, Formica M, Krcmar M, Quinn AL, Mebrahtu Y, Ruslins A, Street R, Wannan C, Dixon L, Carter CS, Loewy R, Niendam TA, Shumway M, Nelson B, Cotter D, Susai S, Yung AR.
PMID: 42383294 [PubMed - indexed for MEDLINE]


Cognitive and emotional empathy in schizophrenia as State-independent impairment: A multidimensional task paradigm study.
Indian J Psychiatry
Chouhan P, Gogoi V, Datta A, Abhishek P.
PMID: 42381848 [PubMed]


Hippocampal subfield radiomics improves identification of in-hospital aggressive behavior in schizophrenia: an interpretable machine-learning study.
BMC Psychiatry
Wang JX, Wang RC, Xu FL, Li Y, Yang Y, Li YF.
PMID: 42380940 [PubMed - as supplied by publisher]


The effectiveness of participation in group sports-recreational activities on the quality of life of patients with schizophrenia.
Discov Ment Health
Abedanzadeh R, Sepehrikia M, Hashemi A.
PMID: 42380729 [PubMed - as supplied by publisher]


Author Correction: Digital AVATAR therapy for distressing voices in psychosis: the phase 2/3 AVATAR2 trial.
Nat Med
Garety PA, Edwards CJ, Jafari H, Emsley R, Huckvale M, Rus-Calafell M, Fornells-Ambrojo M, Gumley A, Haddock G, Bucci S, McLeod HJ, McDonnell J, Clancy M, Fitzsimmons M, Ball H, Montague A, Xanidis N, Hardy A, Craig TKJ, Ward T.
PMID: 42380679 [PubMed - as supplied by publisher]


Characterizing the Availability and Quality of CBT for Psychosis in the United States and Canada: Results From a Survey of Early Intervention for Psychosis Programs.
Early Interv Psychiatry
Eisen K, Wood HJ, Thompson E, Kopelovich SL, Lecomte T, Murphy C, Reznik SJ, Shapiro D, Sivec H, Hardy KV.
PMID: 42380050 [PubMed - indexed for MEDLINE]


Interventions to support recovery of people with psychosis in low-income and middle-income countries: a systematic review.
Lancet Psychiatry
Barber S, McPhail L, Xue S, Greenley R, Jia C, Assefa E, Fekadu W, Mihretu A, Weir H, Keynejad RC, West E, Chatterjee S, Cleary S, Chiliza B, Eaton J, Sunkel C, Morgan C, Malla AK, Hanlon C.
PMID: 42379205 [PubMed - as supplied by publisher]


Psychosis, human rights, and legal frameworks: global perspectives, with a focus on low-income and middle-income countries.
Lancet Psychiatry
Gooding P, Kumar S, Encalada AV, Juan NVS, Chen B, Dutta J, Toncón-Chaparro L, Pathare S.
PMID: 42379204 [PubMed - as supplied by publisher]


Sense of Coherence in patients with stable schizophrenia: multidimensional determinants from a cross-sectional study of 438 inpatients in Guangzhou, China.
Front Psychiatry
Liang R, Niu Z, Huang Y, Chen X, Wu F, Chen X, Liu C, Shi X, Zeng G.
PMID: 42376252 [PubMed]


Mapping personal recovery in schizophrenia spectrum disorders: an exploratory machine learning study of self-reported stage classifications.
Front Public Health
Pérez-Ramos A, Plasse J, Chéreau-Boudet I, Gouache B, Legros-Lafarge E, Guillard-Bouhet N, Franck N, Barbalat G.
PMID: 42375587 [PubMed - indexed for MEDLINE]


Neuroanatomical and transcriptomic correlates of attention in schizophrenia.
Schizophr Res Cogn
Lu HL, Wang XF, Wu D, Zhang YJ, Wu WJ, Zhang YH, Zhang HJ, Li D, Strelnikov K, Wang HN, Wei Y, Chang X, Cui LB.
PMID: 42375217 [PubMed]


Defining a recovery definition and core outcomes of psychosis: protocol of an international Delphi consensus study.
East Asian Arch Psychiatry
Starzer M, Hansen HG, Ghanem J, Percie du Sert O, Festervoll A, Simonsen C, Jonas K, Li C, Wong CTW, Lepage M, Ma DCF, Kotov R, Nordentoft M, Albert N, Hegelstad WTV, Weibell M, Clarke M, Chan SKW.
PMID: 42374953 [PubMed - indexed for MEDLINE]


Single-cell eQTL and Mendelian randomization analyses of shared genetic architecture in major depressive disorder and schizophrenia.
J Affect Disord
Ren J, Dong B, Li X, Meng X.
PMID: 42372879 [PubMed - as supplied by publisher]


Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.
Schizophr Res
Lappin JM, Bolton P, Smith G, Chua XY, Grattan S, Samaras K, Day R, Popovic G, O'Donnell M, Buten S, Hansen J, Teasdale S, Wong T, El-Omar E.
PMID: 42372344 [PubMed - as supplied by publisher]


Nighttime light exposure is associated with metabolic dysfunction in schizophrenia: A cross-sectional analysis of the LENS study.
Sleep
Taniguchi R, Esaki Y, Obayashi K, Saeki K, Tsuboi S, Fujita K, Iwata N, Kitajima T.
PMID: 42372068 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 69221    Page 1 of 3462  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1